CAR-T cell therapy in cancer immunotherapy – Biology, clinical successes, and emerging challenges: A review

Abdisa Tufa Bedada, Mohammed Mehdi, Ousman Mohammed · 2026

Read CAR-T cell therapy in cancer immunotherapy – Biology, clinical successes, and emerging challenges: A review by Abdisa Tufa Bedada, Mohammed Mehdi, Ousman Mohammed (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13394578.txt.

Description

Abdisa Tufa Bedada and colleagues review CAR-T cell therapy in cancer immunotherapy in a 2026 paper. Engineered T cells redirected against tumor antigens have transformed care for relapsed blood cancers, yet design, manufacturing, resistance, and toxicity questions remain.

The review traces CAR architecture from first-generation constructs to armored and fifth-generation designs, compares viral and non-viral gene delivery, and surveys in vivo engineering, off-the-shelf allogeneic products, logic-gated receptors, and safety switches. Readers gain a full tour of how CAR-T works, where it succeeds, and what must improve next.

Catalog record

CREATORAbdisa Tufa Bedada, Mohammed Mehdi, Ousman Mohammed
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE69 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13394578

Browse the full library · About the Tower of Babel